DatChem is proud to share that two of our core technology patents have been approved by the US patent office!

METHOD AND SYSTEM FOR ACQUIRING SPECTRAL DATA FOR USE IN ASSESSING RISK OF BREAST CANCER.

and

METHOD AND SYSTEM FOR ACQUIRING SPECTRAL DATA FROM HEALTHY BREAST TISSUE FOR USE IN DETECTING BREAST CANCER DEVELOPMENT.

Watch this space for the results of the ten year blinded longitudinal study, based on this technology, which identifies the risk and tissue changes towards breast cancer four years on average ahead of current methods. With this time, a woman can be managed and cured.